Online citations, reference lists, and bibliographies.

In Stent Restenosis: Bane Of The Stent Era

Amit K Mitra, Dr. Karnika Agrawal
Published 2006 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
The long term outcome of stent implantation is affected by a process called in stent restenosis (ISR). Multiple contributory factors have been identified, but clear understanding of the overall underlying mechanism remains an enigma. ISR progresses through several different phases and involves numerous cellular and molecular constituents. Platelets and macrophages play a central role via vascular smooth muscle cell migration and proliferation in the intima to produce neointimal hyperplasia, which is pathognomic of ISR. Increased extracellular matrix formation appears to form the bulk of the neointimal hyperplasia tissue. Emerging evidence of the role of inflammatory cytokines and suppressors of cytokine signalling make this an exciting and novel field of antirestenosis research. Activation of Akt pathway triggered by mechanical stretch may also be a contributory factor to ISR formation. Prevention of ISR appears to be a multipronged attack as no therapeutic “magic bullet” exists to block all the processes in one go.
This paper references
10.1161/01.CIR.98.16.1657
Apoptosis and cell proliferation after porcine coronary angioplasty.
Nadim Malik (1998)
10.1016/0092-8674(90)90801-K
Signal transduction by receptors with tyrosine kinase activity
Axel Ullrich (1990)
10.1016/S0140-6736(96)98005-8
The role of infection in restenosis and atherosclerosis: focus on cytomegalovirus
SE Epstein (1996)
10.1136/hrt.49.4.393
Transluminal coronary angioplasty and early restenosis. Fibrocellular occlusion after wall laceration.
Catharina E. Essed (1983)
10.1016/S0002-9149(02)03147-8
New frontiers and unresolved controversies in percutaneous coronary intervention.
Vladimír Dz̆avík (2003)
10.1016/0968-0004(94)90132-5
MAPKs: new JNK expands the group.
Roger J. Davis (1994)
Basic concepts and implications in coronary artery disease
P J Best (1999)
10.1161/01.CIR.103.13.1718
Inflammation and thrombosis: the clot thickens.
Peter Libby (2001)
Human atherosclerosis. I. Cell constitution and characteristics of advanced lesions of the superficial femoral artery.
Russell T. Ross (1984)
10.1161/01.CIR.82.1.69
Coronary atherectomy. Clinical, angiographic, and histological findings and observations regarding potential mechanisms.
Robert D Safian (1990)
10.1038/284555a0
Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation
Andrew H. Wyllie (1980)
10.1038/bjc.1972.33
Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics
J. F. R. Kerr (1972)
10.1083/jcb.119.3.493
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
Y Gavrieli (1992)
10.1101/gad.13.15.1899
BCL-2 family members and the mitochondria in apoptosis.
A Gross (1999)
10.1016/S0092-8674(00)80405-5
Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death Machinery
Sandeep Robert Datta (1997)
10.1161/01.CIR.98.17.1802
Frontiers in interventional cardiology.
Eric J. Topol (1998)
10.1006/jmcc.1998.0795
Regulation of vascular smooth muscle migration by mitogen-activated protein kinase and calcium/calmodulin-dependent protein kinase II signaling pathways.
Martha S. Lundberg (1998)
10.1161/01.RES.67.3.651
Time course of smooth muscle cell proliferation in the intima and media of arteries following experimental angioplasty.
Hartmut Hanke (1990)
10.1161/01.RES.87.4.282
Ceramide-Coated Balloon Catheters Limit Neointimal Hyperplasia After Stretch Injury in Carotid Arteries
Rhonda Charles (2000)
10.1161/01.CIR.95.4.981
Evidence for the rapid onset of apoptosis in medial smooth muscle cells after balloon injury.
Harris R Perlman (1997)
10.1007/s11883-000-0075-3
Gene therapy for myocardial angiogenesis: Has it come of age?
Birgit Kantor (2000)
10.1016/0092-8674(93)90464-2
A novel domain within the 55 kd TNF receptor signals cell death
Louis A. Tartaglia (1993)
10.1016/S0092-8674(00)81589-5
Bid, a Bcl2 Interacting Protein, Mediates Cytochrome c Release from Mitochondria in Response to Activation of Cell Surface Death Receptors
Xu Luo (1998)
10.1101/gad.10.22.2859
BID: a novel BH3 domain-only death agonist.
Kun Wang (1996)
10.1161/01.CIR.100.18.1872
Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome.
Roxana Mehran (1999)
10.1038/25141
Control of apoptosis and mitotic spindle checkpoint by survivin
Fengzhi Li (1998)
10.1016/S0002-9149(99)00910-8
Effect of statin therapy on restenosis after coronary stent implantation.
Dirk Walter (2000)
10.1161/01.CIR.86.1.71
Excimer Laser‐Facilitated Coronary Angioplasty: Relative Risk Analysis of Acute and Follow‐up Results in 200 Patients
John A Bittl (1992)
10.1161/01.atv.21.3.327
Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty.
Francesco Cipollone (2001)
10.1161/01.ATV.17.7.1203
Smooth muscle cell heterogeneity in pulmonary and systemic vessels. Importance in vascular disease.
Maria G. Frid (1997)
Kinetics of cellular proliferation after arterial injury. II. Inhibition of smooth muscle growth by heparin.
Alexander W. Clowes (1985)
10.1161/01.RES.84.1.113
Determinants of vascular smooth muscle cell apoptosis after balloon angioplasty injury. Influence of redox state and cell phenotype.
Matthew J. Pollman (1999)
10.1016/S0735-1097(98)00286-1
The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation.
Andrea C. Abizaid (1998)
10.1002/ccd.20054
Use of IIb/IIIa inhibitors in patients with in-stent restenosis treated with intracoronary gamma-radiation. Integrilin WRIST.
Ron Waksman (2004)
10.1016/0735-1097(94)90126-0
Morphologic characteristics of lesion formation and time course of smooth muscle cell proliferation in a porcine proliferative restenosis model.
Andrew James Carter (1994)
10.1126/science.281.5381.1312
Caspases: enemies within.
Nancy Ann Thornberry (1998)
10.1161/01.CIR.94.7.1655
Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries.
Y Shi (1996)
10.1161/01.CIR.0000019071.72887.BD
Morphological Predictors of Restenosis After Coronary Stenting in Humans
Andrew Farb (2002)
The Potential of Cilostazol in Interventional Cardiology.
Tsuchikane (2000)
10.1080/14628840310022117-1
Neointimal vascularization and intimal thickening in response to self‐expanding stents: a swine model
Rona Shofti (2004)
Pathophysiology of coronary artery restenosis.
Robert S. Schwartz (2002)
10.1378/chest.126.3_suppl.576S
Antithrombotic therapy during percutaneous coronary intervention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Jeffrey J. Popma (2004)
10.1067/mhj.2001.111548
Effects of cilostazol on late lumen loss and repeat revascularization after Palmaz-Schatz coronary stent implantation.
Ken Kozuma (2001)
10.1096/fj.01-0658com
Hypoxia enhances vascular cell proliferation and angiogenesis in vitro via rapamycin (mTOR)-dependent signaling.
Rok Humar (2002)
10.1016/0092-8674(94)90534-7
p53-Dependent apoptosis suppresses tumor growth and progression in vivo
Holly Symonds (1994)
10.1126/science.278.5338.687
Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt.
Luis del Peso (1997)
10.1056/NEJM199408253310801
A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group.
P. W. Serruys (1994)
10.1016/S0735-1097(85)80174-1
Intimal proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty.
Garth E. Austin (1985)
10.1053/hj.1999.v137.90600
Is all unstable angina the same? insights from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I). The CAVEAT-Investigators.
Robert A. Harrington (1999)
10.1161/01.ATV.17.11.2383
Apoptosis after stent implantation compared with balloon angioplasty in rabbits. Role of macrophages.
Marc Kollum (1997)
10.1016/S0092-8674(00)81590-1
Cleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis
Honglin Li (1998)
10.1126/science.8023160
Potential role of human cytomegalovirus and p53 interaction in coronary restenosis.
Edith Speir (1994)
10.1161/01.CIR.0000105724.30980.CD
Antirestenotic Effects of a Locally Delivered Caspase Inhibitor in a Balloon Injury Model
Nirat Beohar (2004)
10.1161/01.CIR.94.6.1239
Increased neutrophil-platelet adhesion in patients with unstable angina.
Ilka Ott (1996)
10.1161/01.CIR.100.6.614
Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes.
Pål Aukrust (1999)
10.1172/JCI117504
Reperfusion injury induces apoptosis in rabbit cardiomyocytes.
Roberta A Gottlieb (1994)
Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium.
Alexander W. Clowes (1983)
10.1161/01.CIR.89.4.1511
Localization of insulin-like growth factor I and inhibition of coronary smooth muscle cell growth by somatostatin analogues in human coronary smooth muscle cells. A potential treatment for restenosis?
Maria B Grant (1994)
10.1111/j.1523-1755.2005.00261.x
Risk factors for coronary artery disease, circulating endothelial progenitor cells, and the role of HMG-CoA reductase inhibitors.
Carmen Urbich (2005)
Cardiovascular disease and insulin-like growth factor I. Circulation 2002;106:893–5
J Frystyk (2002)
10.1038/nsb0796-619
The three-dimensional structure of apopain/CPP32, a key mediator of apoptosis
Jennifer Rotonda (1996)
10.1097/00019501-199608000-00002
Upregulation of IGF‐I and collagen I mRNA in human atherosclerotic tissue is not accompanied by changes in type 1 IGF receptor or collagen III mRNA: an in situ hybridization study
V J Wilson (1996)
10.1038/sj.onc.1202568
Modulation of life and death by the TNF receptor superfamily
Stacey J. Baker (1998)
10.1161/01.CIR.97.3.276
Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor.
Hiroyuki Yaoita (1998)
10.1074/jbc.274.2.1156
Caspase Cleaved BID Targets Mitochondria and Is Required for Cytochrome c Release, while BCL-XL Prevents This Release but Not Tumor Necrosis Factor-R1/Fas Death*
Atan Gross (1999)
10.1172/JCI116352
Proliferative activity in peripheral and coronary atherosclerotic plaque among patients undergoing percutaneous revascularization.
J. Geoffrey Pickering (1993)
10.1161/01.RES.71.4.759
Rat carotid neointimal smooth muscle cells reexpress a developmentally regulated mRNA phenotype during repair of arterial injury.
Mark W. Majesky (1992)
10.1016/S0008-6363(99)00355-7
Incidence of intimal proliferation and apoptosis following balloon angioplasty in an atherosclerotic rabbit model.
Joachim Kamenz (2000)
10.1056/NEJM198703193161201
Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty.
Ulrich Sigwart (1987)
10.1161/hq1101.098230
Angiogenesis, Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor-BB Expression, Iron Deposition, and Oxidation-Specific Epitopes in Stented Human Coronary Arteries
Jan Hinrich Braesen (2001)
10.1042/bj3350001
Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation.
Paul J. Coffer (1998)
10.1126/science.281.5381.1305
Death receptors: signaling and modulation.
Avi Ashkenazi (1998)
10.1053/euhj.2001.2893
Direct coronary stenting versus stenting with balloon pre-dilation: immediate and follow-up results of a multicentre, prospective, randomized study. The DISCO trial. DIrect Stenting of COronary Arteries.
Luis Martínez-Elbal (2002)
10.1016/0735-1097(90)90386-4
Plaque morphology and pathologic changes in arteries from patients dying after coronary balloon angioplasty.
Andrew Farb (1990)
10.1161/01.CIR.0000103700.05109.0D
Preprocedural Level of Soluble CD40L Is Predictive of Enhanced Inflammatory Response and Restenosis After Coronary Angioplasty
Francesco Cipollone (2003)
Protein kinase C zeta isoform is critical for mitogenic signal transduction.
Edurne Berra (1993)
10.1038/sj.bjp.0703336
Caspase inhibition and limitation of myocardial infarct size: protection against lethal reperfusion injury.
Mihaela M. Mocanu (2000)
10.1161/01.ATV.19.1.14
Apoptosis. Basic concepts and implications in coronary artery disease.
Patricia J. M. Best (1999)
10.1016/j.cardiores.2004.06.010
T-cadherin upregulation correlates with cell-cycle progression and promotes proliferation of vascular cells.
Danila Ivanov (2004)
10.1016/0092-8674(95)90411-5
Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces bax and promotes cell death
Elizabeth Yang (1995)
10.1042/bj3080697
Cyclins and cyclin-dependent kinases: a biochemical view.
Jonathon Pines (1995)
10.1067/mva.2001.109774
Relationship of glycosaminoglycan and matrix changes to vascular smooth muscle cell phenotype modulation in rabbit arteries after acute injury.
John A. Bingley (2001)
10.1097/00041433-199912000-00004
Pathology of in-stent restenosis.
Renu Virmani (1999)
10.1016/S0735-1097(00)00528-3
Inhibition of neointima formation by tranilast in pig coronary arteries after balloon angioplasty and stent implantation.
Sugao Ishiwata (2000)
10.1161/01.CIR.97.25.2511
Lower expression of neutrophil adhesion molecule indicates less vessel wall injury and might explain lower restenosis rate after cutting balloon angioplasty.
Tetsufumi Inoue (1998)
10.1016/S0002-9149(00)01001-8
Effects of cilostazol on angiographic restenosis after coronary stent placement.
Soeun Park (2000)
10.1038/35393
CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells
Volker Henn (1998)
Structure and mechanism of interleukin-1 beta converting enzyme.
Keith D. P. Wilson (1994)
10.1016/j.cardiores.2004.03.028
The role of perlecan in arterial injury and angiogenesis.
Amit Segev (2004)
10.1093/emboj/17.8.2215
IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases.
Quinn L. Deveraux (1998)
10.1161/01.RES.81.6.904
Activation of MAP kinase in vivo follows balloon overstretch injury of porcine coronary and carotid arteries.
John M. Pyles (1997)
10.1182/blood.V83.9.2498.bloodjournal8392498
Role of P-selectin and leukocyte activation in polymorphonuclear cell adhesion to surface adherent activated platelets under physiologic shear conditions (an injury vessel wall model).
Erik L. Yeo (1994)
10.1016/0002-9149(94)90545-2
Long-term angiographic and clinical outcome after implantation of balloon-expandable stents in aortocoronary saphenous vein grafts.
S H Fenton (1994)
10.1126/science.8047883
Gene therapy for vascular smooth muscle cell proliferation after arterial injury.
Tsuneya Ohno (1994)
10.1074/jbc.M101590200
Bcl-x l Promotes the Open Configuration of the Voltage-dependent Anion Channel and Metabolite Passage through the Outer Mitochondrial Membrane*
Matthew G. Vander Heiden (2001)
10.1161/01.RES.75.3.426
Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes.
M. Tanaka (1994)
10.1101/gad.9.10.1149
Inhibitors of mammalian G1 cyclin-dependent kinases.
Charles J Sherr (1995)
10.1016/1054-8807(96)80374-7
Phenotypic heterogeneity of rat arterial smooth muscle cell clones. Implications for the development of experimental intimal thickening.
M L Bochaton-Piallat (1996)
10.1161/01.CIR.93.12.2178
Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries.
Neal A. Scott (1996)
10.2174/1570161033386709
Role of the growth suppressor p27Kip1 during vascular remodeling.
Antonio Díez-Juan (2003)
10.1016/S1062-1458(01)00318-X
Endoluminal beta-radiation therapy for the prevention of coronary restenosis after balloon angioplasty. The Dose-Finding Study Group.
V Verin (2001)
A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen.
Naoto Itoh (1993)
10.1091/mbc.4.9.953
The extracellular matrix as a cell survival factor.
Jere Ernest Meredith (1993)
10.1161/01.CIR.97.9.857
Abciximab therapy and unplanned coronary stent deployment: favorable effects on stent use, clinical outcomes, and bleeding complications. EPILOG Trial Investigators.
Dean J Kereiakes (1998)
10.1146/annurev.cellbio.15.1.269
Biochemical pathways of caspase activation during apoptosis.
Imawati Budihardjo (1999)
10.1161/01.CIR.30.5.654
Transluminal Treatment of Arteriosclerotic Obstruction: Description of a New Technic and a Preliminary Report of Its Application
Charles T. Dotter (1964)
10.1016/S0735-1097(98)00404-5
Angiographic and intravascular ultrasound predictors of in-stent restenosis.
Shunji Kasaoka (1998)
Update on In-stent Restenosis.
Magdi M. El-Omar (2001)
10.1016/S0735-1097(00)00895-0
Troglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with non-insulin dependent diabetes mellitus: a serial intravascular ultrasound study.
Takuro Takagi (2000)
Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 1996;87:619–28
J Zha (1996)
10.1016/S1062-1458(00)00179-3
Final results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) study.
Peter J. Fitzgerald (2000)
Valsartan for prevention of restenosis after stenting of type B2/C lesions: the VAL-PREST trial.
Stefan Peters (2001)
10.1055/s-0038-1642737
The three processes leading to post PTCA restenosis: dependence on the lesion substrate.
Valentin Fuster (1995)
10.1016/j.amjcard.2004.08.037
Angiographic and clinical outcomes of late total occlusion versus treatment failure without late total occlusion in patients after intracoronary radiation therapy for in-stent restenosis.
Roswitha M. Wolfram (2004)
10.1016/S0002-8703(00)90304-1
The PRESTO (Prevention of restenosis with tranilast and its outcomes) protocol: a double-blind, placebo-controlled trial.
David R. Holmes (2000)
10.1161/01.atv.0000105902.89459.09
Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels.
Patrice Delafontaine (2004)
10.1056/NEJM199408253310802
A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators.
David L Fischman (1994)
10.1146/annurev.biochem.69.1.217
Apoptosis signaling.
Andreas Strasser (2000)
A comparison of balloonexpandable-stent implantation with balloon angioplasty in patients with coronary artery disease
PW Serruys (1994)
10.1016/0002-9149(86)90272-9
Early and late morphologic changes after transluminal balloon angioplasty of the iliac arteries.
V Mittal (1986)
10.1016/S0968-0004(97)01043-8
The CARD domain: a new apoptotic signalling motif.
Kay Hofmann (1997)
10.1161/01.CIR.102.24.2945
Percutaneous Coronary Intervention in the Current Era Compared With 1985–1986: The National Heart, Lung, and Blood Institute Registries
David O. Williams (2000)
10.1136/heart.89.2.133
Drug eluting stents: are human and animal studies comparable?
Renu Virmani (2003)
10.1016/S0092-8674(00)81382-3
Serine Phosphorylation of Death Agonist BAD in Response to Survival Factor Results in Binding to 14-3-3 Not BCL-XL
Jiping Zha (1996)
10.1002/path.1711050103
Shrinkage necrosis: a distinct mode of cellular death.
J. F. R. Kerr (1971)
10.1016/0002-9149(91)90220-F
Growth factors in pathogenesis of coronary arterial restenosis.
Bojan Cercek (1991)
10.1016/S0735-1097(10)80071-3
Primary peripheral arterial stenoses and restenoses excised by transluminal atherectomy: a histopathologic study.
Donald E. Johnson (1990)
10.1586/14779072.1.2.233
Use of GPIIb/IIIa inhibitors in cardiovascular medicine
I. G. Ahrens (2003)
10.1097/00019501-199609000-00007
Platelet activation and restenosis after coronary stenting: flow cytometric detection of wound‐induced platelet activation
Jerome H. Markovitz (1996)
10.1016/S0167-5273(01)00388-6
Effect of cilostazol on restenosis after coronary angioplasty and stenting in comparison to conventional coronary artery stenting with ticlopidine.
Yasutaka Tanabe (2001)
10.1152/ajplung.1992.263.2.L276
IGF-I regulation of elastogenesis: comparison of aortic and lung cells.
Celeste B. Rich (1992)
10.1038/23730
Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis
Xiao-Ming Yin (1999)
10.1161/01.CIR.0000030720.29247.9F
Cardiovascular disease and insulin-like growth factor I.
Jan Frystyk (2002)
10.1002/(SICI)1096-9896(200002)190:3<300::AID-PATH596>3.0.CO;2-I
Molecular mechanisms in intimal hyperplasia.
Andrew C Newby (2000)
10.1152/physrev.1979.59.1.1
The smooth muscle cell in culture.
Jh Chamleycampbell (1979)
10.1161/01.CIR.101.5.524
Characteristics of coronary smooth muscle cells and adventitial fibroblasts.
Seema Patel (2000)
10.1016/S0962-8924(98)01321-X
Bcl-2-family proteins: the role of the BH3 domain in apoptosis.
Ameeta Kelekar (1998)
10.1182/blood.V88.1.146.bloodjournal881146
Neutrophil rolling, arrest, and transmigration across activated, surface-adherent platelets via sequential action of P-selectin and the beta 2-integrin CD11b/CD18.
Thomas G. Diacovo (1996)
10.1161/01.CIR.98.3.224
Neointimal tissue response at sites of coronary stenting in humans: macroscopic, histological, and immunohistochemical analyses.
Ryushi Komatsu (1998)
Drug eluting stents: are human and animal studies comparable? Heart 2003;89:133–8
R Virmani (2003)
10.1172/JCI118481
Differentiated vascular myocytes: are they involved in neointimal formation?
Bruce Holifield (1996)
10.1161/01.CIR.98.16.1604
Stenting after optimal lesion debulking (sold) registry. Angiographic and clinical outcome.
Issam Moussa (1998)
10.1016/S0065-230X(00)79001-4
New paradigms for the treatment of cancer: the role of anti-angiogenesis agents.
Julie M. Cherrington (2000)
10.1161/01.CIR.95.12.2684
Remodeling of autologous saphenous vein grafts. The role of perivascular myofibroblasts.
Y Shi (1997)
10.1016/S0140-6736(98)11086-3
Platelet GPIIb-IIIa blockers
Eric J. Topol (1999)
New Frontiers in Interventional Cardiology: Intravascular Radiation to Prevent Restenosis
Paul S. Teirstein (2001)
10.1097/01.RVI.0000127888.70058.93
Stent-based controlled release of intravascular angiostatin to limit plaque progression and in-stent restenosis.
Fumikiyo Ganaha (2004)
10.1126/science.281.5381.1322
The Bcl-2 protein family: arbiters of cell survival.
Jerry M. Adams (1998)
10.1161/01.CIR.82.6.2190
Restenosis after balloon angioplasty. A practical proliferative model in porcine coronary arteries.
Robert S. Schwartz (1990)
10.1161/01.ATV.17.10.1868
Cellular heterogeneity of the vascular tunica media. Implications for vessel wall repair.
Charles L. Seidel (1997)
10.1172/JCI118280
Stretch-induced programmed myocyte cell death.
W Cheng (1995)
10.1136/heart.89.2.218
IN-STENT STENOSIS: PATHOLOGY AND IMPLICATIONS FOR THE DEVELOPMENT OF DRUG ELUTING STENTS
Martin Bennett (2003)
10.1093/emboj/18.3.632
Bcl-xL regulates apoptosis by heterodimerization-dependent and -independent mechanisms.
Andy J. Minn (1999)
10.1016/S0735-1097(10)80113-5
Differential histopathology of primary atherosclerotic and restenotic lesions in coronary arteries and saphenous vein bypass grafts: analysis of tissue obtained from 73 patients by directional atherectomy.
Kirk N Garratt (1991)
10.1093/geronj/45.4.B113
Effect of age and IGF-I administration on elastin gene expression in rat aorta.
Judith Ann Foster (1990)
10.1016/S0735-1097(87)80202-4
Arterial changes after percutaneous transluminal coronary angioplasty: results at autopsy.
Kyoji Kohchi (1987)
10.1007/BF00218940
Regenerating endothelial cells express insulin-like growth factor-I immunoreactivity after arterial injury
Hans-Arne Hansson (1987)
10.1161/01.ATV.17.3.417
Vascular myofibroblasts. Lessons from coronary repair and remodeling.
Andrew Zalewski (1997)
10.1161/01.RES.84.3.306
Anti-monocyte chemoattractant protein-1/monocyte chemotactic and activating factor antibody inhibits neointimal hyperplasia in injured rat carotid arteries.
Yasuyuki Furukawa (1999)
10.1016/s1278-3218(97)81506-5
[Catheter-based radiotherapy to inhibit restenosis after coronary stenting].
Horst Sack (1998)
Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions.
Allen M. Gown (1986)
10.1007/s00418-001-0336-4
The involvement of vascular endothelial growth factor and flt-1 in the process of neointimal proliferation in pig coronary arteries following stent implantation
Masayuki Shibata (2001)
10.1161/01.CIR.90.4.2070
Local drug delivery for the prevention of restenosis. Fact, fancy, and future.
Abraham Michael Lincoff (1994)
The end of systemic anticoagulation therapy for restenosis prevention.
George D Dangas (2001)
10.1097/00132586-199908000-00006
A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.
M. Bonilla León (1998)
10.1016/S0968-0004(97)01097-9
PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond.
Barbara M. Marte (1997)
10.1016/S0735-1097(97)00510-X
Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease.
Mark I. Furman (1998)
10.1073/pnas.87.12.4600
Cell proliferation in human coronary arteries.
Daphna Gordon (1990)
10.1161/01.CIR.102.9.951
Inhibition of Restenosis With &bgr;-Emitting Radiotherapy: Report of the Proliferation Reduction With Vascular Energy Trial (PREVENT)
Albert E. Raizner (2000)
10.1161/01.CIR.94.1.35
Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study.
Gary S. Mintz (1996)
10.1016/S0968-0004(97)01085-2
Caspases: killer proteases.
Donald W. Nicholson (1997)
10.1023/A:1013964517211
Plasminogen Activators in Vascular Remodeling and Angiogenesis
Ye. V. Parfyonova (2002)
10.1016/S0735-1097(97)00334-3
Predictive factors of restenosis after coronary stent placement.
Adnan Kastrati (1997)
10.1161/01.CIR.91.11.2703
Apoptosis in human atherosclerosis and restenosis.
Jeffrey M. Isner (1995)
10.1111/j.1476-5381.1995.tb14953.x
Inhibition of rabbit aortic smooth muscle cell proliferation by selective inhibitors of protein kinase C.
Andrew C Newby (1995)
10.1016/S0092-8674(00)00008-8
Smac, a Mitochondrial Protein that Promotes Cytochrome c–Dependent Caspase Activation by Eliminating IAP Inhibition
Chunying Du (2000)
Transluminal treatment of arteriosclerotic obstruction. Description of a new technique and a preliminary report of its application. Circulation 1964;30:654–70
CT Dotter (1964)



This paper is referenced by
10.1080/02652040903046798
Ultrasonic atomization and subsequent desolvation for monoclonal antibody (mAb) to the glycoprotein (GP) IIIa receptor into drug eluting stent.
Gui-xue Wang (2010)
10.1155/2017/9548612
Association between VEGF Gene Polymorphisms and In-Stent Restenosis after Coronary Intervention Treated with Bare Metal Stent
Zsolt Bagyura (2017)
he effect of alpha lipoic acid in a porcine in-stent estenosis model
ang Yup Lim (2009)
10.1161/CIRCULATIONAHA.112.119479
Cell Selective Cardiovascular Biology of Microsomal Prostaglandin E Synthase-1
Lihong Chen (2013)
10.1179/1743284713Y.0000000473
Simulation study on uneven expansion behaviour of biodegradable magnesium alloy stents by finite element analysis
Jie Li (2014)
LOCAL-TAX Studie. Lokale intrakoronare Gabe von Paclitaxel nach Stentimplantation zur Verhinderung einer Restenose im Vergleich zu Stentimplantation alleine und zur Implantation eines Paclitaxel-beschichteten Stents
Abteilung für Innere Medizin (2010)
10.1007/s10735-011-9316-8
Improved protocol for processing stented porcine coronary arteries for immunostaining
Arun H. S. Kumar (2011)
10.1016/j.actbio.2009.11.025
Fe-Mn alloys for metallic biodegradable stents: degradation and cell viability studies.
Hendra Hermawan (2010)
10.1258/vasc.2010.oa0268
Histological analysis of cobalt–chromium stents with and without Camouflage® polymer coating: experimental porcine carotid artery model
Marco Aurélio Grudtner (2011)
10.1371/journal.pone.0142075
Surface Modification of Biodegradable Polymers towards Better Biocompatibility and Lower Thrombogenicity
Andreas Rudolph (2015)
Development of reinforced and cell-laden vascular grafts structurally inspired by human coronary artery
Tamara L. Akentjew (2017)
10.1042/CS20100400
IGF-1 and atherothrombosis: relevance to pathophysiology and therapy.
Elena Conti (2011)
10.1007/s10439-015-1413-5
A Review of Material Degradation Modelling for the Analysis and Design of Bioabsorbable Stents
Enda L Boland (2015)
10.1016/j.jacc.2010.09.029
Microribonucleic acids for prevention of plaque rupture and in-stent restenosis: "a finger in the dam".
John O'Sullivan (2011)
10.1524/teme.2011.0134
Micro-Particle-Image-Velocimetry zur Bestimmung der Geschwindigkeiten in einem Koronargefäß mit Stent
Daniel Quosdorf (2011)
10.1016/S0120-5633(12)70118-3
Caracterización de la restenosis de stents coronarios convencionales y liberadores de medicamentos en pacientes incluidos en el registro DRug Eluting STent (DREST)
A C Jorge Arroyave (2012)
10.1186/s12872-017-0603-5
Efficacy and safety of polymer-free stent versus polymer-permanent drug-eluting stent in patients with acute coronary syndrome: a meta-analysis of randomized control trials
Kang Gao (2017)
10.1016/j.cbi.2019.03.002
Inhibition of mitochondrial complex I activity attenuates neointimal hyperplasia by inhibiting smooth muscle cell proliferation and migration.
Jie Yin (2019)
The involvement of modified lipids in vascular injury and disease
Fiona H. Greig (2013)
10.1088/2053-1591/AB27EE
Modified mechanical properties of Mg-Nd-Zn-Ag-Zr alloy by solution treatment for cardiovascular stent application
Shuojie Wang (2019)
10.1021/acsami.9b12258
Differential Phagocytosis-Based Photothermal Ablation of Inflammatory Macrophages in Atherosclerotic Disease.
Xuxu Wang (2019)
10.3109/02652040903046798
Ultrasonic atomization and subsequent desolvation for monoclonal antibody (mAb) to the glycoprotein (GP) IIIa receptor into drug eluting stent
G. X. Wang (2010)
10.1016/j.actbio.2019.01.059
Micropatterning of a 2-methacryloyloxyethyl phosphorylcholine polymer surface by hydrogenated amorphous carbon thin films for endothelialization and antithrombogenicity.
Kenta Bito (2019)
10.1016/j.compbiomed.2014.06.015
Numerical models of net-structure stents inserted into arteries
Moshe Brand (2014)
10.1111/joic.12153
Effect of Angiotensin converting enzyme inhibitors on soluble tumor-necrosis-factor-related apoptosis-inducing ligand levels - association with neointimal hyperplasia in drug eluting stents.
Georgios Giannopoulos (2014)
10.1002/jbm.b.31918
Magnesium used in bioabsorbable stents controls smooth muscle cell proliferation and stimulates endothelial cells in vitro.
Katrin Sternberg (2012)
10.1016/j.actbio.2011.05.032
A corrosion model for bioabsorbable metallic stents.
James A. Grogan (2011)
10.1117/1.3533313
Stent-induced coronary artery stenosis characterized by multimodal nonlinear optical microscopy.
H Wang (2011)
10.1016/j.colsurfb.2016.01.009
Synergistic effect of anti-platelet and anti-inflammation of drug-coated Co-Cr substrates for prevention of initial in-stent restenosis.
Eugene Lih (2016)
Thrombose aiguë d'un tuteur médicamenté
Cynthia Perron (2007)
Vascular stem cell migration in response to Dkk3 in vascular diseases : the emergence of a novel chemokine-like protein
Shirin Issa Bhaloo (2017)
10.1007/S12195-010-0128-9
Effects of Axial Stretch on Cell Proliferation and Intimal Thickness in Arteries in Organ Culture
Yong-Ung Lee (2010)
See more
Semantic Scholar Logo Some data provided by SemanticScholar